A randomized, double-blind, placebo-controlled study of sildenafil (Viagra) in Parkinson's disease men with erectile dysfunction

Trial Profile

A randomized, double-blind, placebo-controlled study of sildenafil (Viagra) in Parkinson's disease men with erectile dysfunction

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Apr 2011

At a glance

  • Drugs Sildenafil (Primary)
  • Indications Erectile dysfunction; Parkinson's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Apr 2011 Status changed from not stated to completed.
    • 16 Apr 2011 Results presented at the 63rd Annual Meeting of the American Academy of Neurology.
    • 23 Aug 2006 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top